m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Fen Liu(Shandong First Medical University), Jianlin Wu(Shandong University of Traditional Chinese Medicine), Ruoyu Cao(Shandong University of Traditional Chinese Medicine), Xianying Li(Donghua University), Shiyu Zhang(The Ohio State University), Qingbin Liu(Jilin Normal University), Yufei Wang(Jining First People's Hospital), Shulong Jiang(Jining First People's Hospital)
Cited by 5
Related Papers
Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC
|Hepatology|2024|60
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
|Frontiers in Pharmacology|2022|53
Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study
|Annals of Intensive Care|2022|41
Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway
|Oncology Letters|2016|37